Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
05/2012
05/17/2012US20120122778 Modified TGF-beta superfamily protein
05/17/2012US20120122770 Cell Cycle Arrest and Apoptosis
05/17/2012US20120122225 Carrier peptide fragment and use thereof
05/17/2012US20120122156 Recombinant protein of fibroblast growth factor having adhesive activity for stem cells and method for culturing stem cells using the same
05/17/2012US20120122153 Acid-clevable linkers exhibiting altered rates of acid hydrolysis
05/17/2012US20120122115 Bacterial quorum sensing biosensor
05/17/2012US20120121709 Phase transition biopolymers and methods of use
05/17/2012US20120121688 Preventative or therapeutic agent and method for immune disease
05/17/2012US20120121659 Functionalized rgd peptidomimetics and their manufacture, and implant having a coating containing such functionalized rgd peptidomimetics
05/17/2012US20120121658 Functionalized rgd peptidomimetics and their manufacture, and implant having a coating containing such functionalized rgd peptidomimetics
05/17/2012US20120121641 Mhc oligomer and method of making the same
05/17/2012US20120121640 OX40/TRAIL Fusion Proteins
05/17/2012US20120121637 Chimeric factor h binding proteins (fhbp) and methods of use
05/17/2012US20120121634 Soluble pd-1 variants, fusion constructs, and uses thereof
05/17/2012US20120121614 Methods and compositions for bi-specific targeting of cd19/cd22
05/17/2012US20120121606 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
05/17/2012US20120121601 Mammalian receptor proteins; related reagents and methods
05/17/2012US20120121591 SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3
05/17/2012US20120121576 Actriia binding agents and uses thereof
05/17/2012US20120121537 Methods and Compositions for Inhibiting Hepatitis C Virus Replication
05/17/2012US20120121512 Monoclonal antibodies and their use
05/16/2012CN102459600A Gene capable of improving productivity of substance in seed, and method for utilization thereof
05/16/2012CN102459348A 用于将gdnf和bdnf递送至中枢神经系统的融合蛋白 Fusion protein is used to gdnf and bdnf delivered to the central nervous system
05/16/2012CN102459329A 治疗性触角足-抗体分子及其使用方法 Therapeutic foot tentacles - antibody molecules and methods of use
05/16/2012CN102455360A 一种新孢子虫病rELISA抗体检测试剂盒 A new neosporosis rELISA antibody detection kit
05/16/2012CN102453097A Angiogenesis inhibiting fusion protein VF and pharmaceutical composition and application thereof
05/16/2012CN102453096A Unlabeled tuberculosis fusion protein ESAT6-Ag85B
05/16/2012CN102453095A Fusion protein containing GLP (glucagon-like peptide)-1 and preparation method and application thereof
05/16/2012CN102453094A Fusion protein containing Exendin-4 and preparation method and application thereof
05/15/2012US8178655 Method and composition for crystallizing G protein-coupled receptors
05/15/2012CA2450476C A soluble complex comprising a retroviral surface glycoprotein
05/15/2012CA2439452C High-affinity antagonists of elr-cxc chemokines
05/15/2012CA2434237C Glp-1 fusion proteins
05/15/2012CA2335098C Protease susceptibility ii
05/10/2012WO2012060120A1 Protein showing specific localization in fat droplets
05/10/2012WO2012059593A1 Vaccines for preventing meningococcal infections
05/10/2012WO2012059592A1 Compounds for delivering a therapeutic or imaging agent to the brain
05/10/2012WO2012037288A8 Methods and compositions for the extracellular transport of biosynthetic hydrocarbons and other molecules
05/10/2012WO2012019157A3 Expression and purification of fusion protein with multiple mbp tags
05/10/2012WO2011139854A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
05/10/2012WO2011139853A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
05/10/2012US20120116057 Design of stable and aggregation free antibody fc molecules through ch3 domain interface engineering
05/10/2012US20120116056 Fc fusion proteins of human growth hormone
05/10/2012US20120116054 Concentrated protein lyophilates, methods, and uses
05/10/2012US20120116053 Expression of triple-helical collagen-like products in e.coli
05/10/2012US20120116052 Nucleic Acid Molecules Encoding TNF-Alpha Ligand Polypeptides Having a CD154 Domain
05/10/2012US20120115790 Therapeutic approach to neurodegenerative disorders using a tfp5-peptide
05/10/2012US20120115202 Photocatalytic hydrogen production in cyanobacteria
05/10/2012US20120114708 Integrin heterodimer and an alpha subunit thereof
05/10/2012US20120114687 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
05/10/2012US20120114684 Compounds and methods for treatment and diagnosis of chlamydial infection
05/10/2012US20120114647 anti-serum album single variable domains
05/10/2012US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells
05/10/2012CA2816584A1 Compositions of a peptide-based system for cell-specific targeting
05/09/2012EP2450373A2 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
05/09/2012EP2448593A2 Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means
05/09/2012CN102449147A Method for highly sensitive detection of protein-protein interaction
05/09/2012CN102449143A Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
05/09/2012CN102443594A Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application
05/09/2012CN102443593A Preparation method for beta-lactamase inhibitory polypeptide and expression vector used therein
05/09/2012CN102443587A Fusion method of human serum albumin and tumor necrosis factor
05/09/2012CN102443065A Preparation for specificity anticoagulant substance and application thereof
05/09/2012CN102443064A Thrombin activity based chimeric peptide with double targeting effects and application thereof
05/09/2012CN102443058A Suppression of B-cell apoptosis in transgenic animals expressing humanized immunoglobulin
05/09/2012CN101891824B Vascular targeting soluble fusion protein TrxHis-hDlll-RGD
05/09/2012CN101475643B Double single chain antibody strengthened fusion protein dFv-LDP-AE, preparation and use thereof
05/09/2012CN101260148B Hybrid and tandem expression of neisserial proteins
05/08/2012US8173782 Fusion protein comprising growth hormone and growth hormone receptor
05/08/2012US8173769 Taste receptors of the T1R family from domestic cat
05/08/2012US8173601 Activin-ActRIIa antagonists and uses for treating multiple myeloma
05/08/2012US8173424 Internalizing ErbB2 antibodies
05/08/2012US8173117 Mouse CX3C chemokine polypeptides
05/08/2012CA1341629C Hepatitis c diagnostics and vaccines
05/03/2012WO2012058588A2 Novel egfr-binding molecules and immunoconjugates thereof
05/03/2012WO2012058363A2 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same
05/03/2012WO2012056683A1 METHOD FOR PRODUCING cAMP USING CHIMERIC OLFACTORY RECEPTOR
05/03/2012WO2012056603A1 METHOD FOR PRODUCING cAMP USING CHIMERIC OLFACTORY RECEPTOR
05/03/2012WO2012055083A1 Fusion protein comprising vegi, pharmaceutical composition and use thereof
05/03/2012WO2012006437A3 Polypeptides having antiviral activity and methods for use thereof
05/03/2012WO2011120013A3 Vista regulatory t cell mediator protein, vista binding agents and use thereof
05/03/2012US20120110693 Targeting nucleic acids in mitochondria
05/03/2012US20120108790 Truncated Somatostatin Receptors
05/03/2012US20120107910 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same
05/03/2012US20120107852 Method for preparing modified polypeptides
05/03/2012US20120107343 Production of recombinant proteins in ciliates and uses thereof
05/03/2012US20120107322 Immunogenic and therapeutic compositions for streptococcus pyogenes
05/03/2012US20120107244 MONOMERIC VARIANTS OF THE TETRAMERIC eqFP611
05/03/2012CA2816379A1 Chimeric cd27 receptors for redirecting t cells to cd70-positive malignancies
05/02/2012EP2445928A1 Chimeric influenza virus-like particles comprising hemagglutinin
05/02/2012EP2445927A1 Lipidated tumor- associated antigens and immunotherapeutic compositions
05/02/2012CN102439045A Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy
05/02/2012CN102439044A In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasing in vivo half-life using same
05/02/2012CN102439043A Hybridization linkers
05/02/2012CN101372513B Sg fusion protein
05/01/2012US8168395 Taste receptors of the T1R family from domestic dog
05/01/2012US8168190 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
05/01/2012CA2468583C Self-assembling multimeric binding complexes derived from ab5 toxin family members
05/01/2012CA2429625C Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof
05/01/2012CA2281620C Neurturin receptor
04/2012
04/26/2012WO2012054580A2 Polyvalent chimeric ospc vaccinogen and diagnostic antigen
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 295